Eton Pharmaceuticals Appoints Judith Matthews as CFO
Eton Pharmaceuticals appointed Judith Matthews as EVP, Accounting and Finance. Matthews will assume the role of CFO effective June 1. The company's current CFO, James Gruber, will then step down as part of a planned succession. To ensure a seamless transition, Gruber will remain in his role through May 31, and will subsequently enter into a six-month consulting agreement with Eton. Prior to joining Eton, she served as CFO of Iterum Therapeutics from 2015 to 2026. Previously, she was Vice President of Finance at Durata Therapeutics until its acquisition by Actavis.
